FDA looks to speed device approval with new partnership

Luke Gale | | Health Exec | Policy & Regulations

The FDA is entering a public-private partnership with the Medical Device Innovation Consortium (MDIC) to help speed the development, assessment and review of new medical devices.

MDIC, a nonprofit created by the trade association LifeScience Alley, will act as an industry arbiter to prioritize regulatory science needs of the medical device community for the allocation of human resources and funding, according to a Dec. 3 statement. The FDA will collaborate with MDIC on various research projects with the hopes of reducing the cost and time it takes for devices to come to market. 

 

Luke Gale

Related Content

More than 1,000 hospitals earn $700M opioid crisis judgment
VA planning 83,000 layoffs as part of restructuring
HIMSS survey report: Beware insider threats to cybersecurity involving AI
HHS spokesperson abruptly resigns, reportedly after clash with RFK
Hospital faces $3.5M settlement after sharing patient data with Facebook
Philips pulls endovascular devices from market after safety issues prompt Class I recall

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.